Ibubeta

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibubeta

Property Description
Active Ingredient Ibuprofen
Form Film-coated tablets, Oral suspension, Suppositories
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common Use Pain relief, fever reduction, anti-inflammatory action
Origin Synthetic compound (Propionic acid derivative)

What Type of Medicine is Ibubeta?

Ibubeta is a recognized trade name for a pharmaceutical preparation containing Ibuprofen, which is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This designation means the medicine is designed to intervene in the body's inflammatory and pain pathways. Chemically, Ibuprofen is a synthetic compound belonging to the class of propionic acid derivatives. Ibuprofen serves as a treatment option for acute discomfort.


Ibubeta's Forms and General Purpose

Ibubeta is produced as a single-ingredient product and is available in common dosage forms, including standard film-coated tablets, specialized oral suspension, and suppositories. The availability of the oral suspension is a distinctive feature, often positioning the brand to cater to pediatric use and adolescents who require accurate dosing and ease of swallowing. The general purpose of this medicine is defined by the core actions of its active ingredient: to alleviate different types of pain, reduce the localized symptoms associated with inflammation such as swelling, and provide relief from fever. The anti-inflammatory action of Ibuprofen supports its utility in addressing both symptomatic pain and the underlying inflammatory response.


Understanding the Core Action (The Analgesic and Antipyretic Effect)

The fundamental function of Ibubeta involves the inhibition of prostaglandin production. Prostaglandins are lipid compounds that act as chemical messengers, triggering pain signals, promoting inflammation, and initiating the body's fever response. This mechanism is used for managing fever associated with colds or general aches. By blocking the enzyme system (cyclooxygenase) responsible for creating these prostaglandins, Ibuprofen provides systemic relief. This core action addresses the body's acute reactive symptoms, providing a mechanism for its generalized analgesic and antipyretic effect.

Regulatory References

  1. EMA Review on Ibuprofen

What side effects are possible with Ibubeta?

Possible Side Effects and Safety Information: Ibubeta

Ibubeta, which belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs), carries documented risks that primarily affect the cardiovascular and gastrointestinal systems. The drug's safety profile is influenced by dose, duration of use, and existing health conditions.

Serious and Clinically Significant Risks

The most serious warnings concern the potential for major adverse cardiovascular thrombotic events, including heart attack and stroke, which may occur early in treatment and increase with prolonged use or higher doses. NSAIDs also significantly increase the risk of serious, potentially fatal gastrointestinal adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines. These complications may occur without warning.

Additionally, severe hypersensitivity reactions (e.g., anaphylaxis or severe skin reactions) are documented, requiring immediate medical attention. Ibuprofen is also associated with potential kidney injury.

Safety Restrictions and Contraindications

Ibubeta is contraindicated in patients with a history of an allergic reaction to aspirin or other NSAIDs, those with active gastrointestinal bleeding or peptic ulcers, and patients undergoing coronary artery bypass graft (CABG) surgery. It is not recommended in the third trimester of pregnancy due to risks to the fetus.

Common Adverse Reactions

Commonly reported, less severe side effects generally involve the gastrointestinal system and include nausea, indigestion (dyspepsia), gas, and diarrhea. Other common reactions are headache, dizziness, and fluid retention (edema).

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information emphasizes that treatment for an Ibubeta overdose is primarily symptomatic and supportive, as there is no specific antidote available.

Documented Overdose Presentations

Symptoms of overdose, based on authoritative government regulatory documents, can range from mild to life-threatening. Initial manifestations often involve the Gastrointestinal System (e.g., nausea, vomiting, abdominal pain) and the Central Nervous System (e.g., drowsiness, dizziness, tinnitus, headache, confusion).

Severe Outcomes and Emergency Action

Regulatory agencies caution that large ingestions may lead to severe, potentially fatal, outcomes. These documented severe outcomes include Gastrointestinal Bleeding or Perforation, Acute Renal Failure, Metabolic Acidosis, Hypotension, and severe CNS depression (e.g., seizures, coma).

Immediate medical help must be sought for any known or suspected overdose, regardless of symptom severity. The official instruction is to get medical help or contact a Poison Control Center right away and not wait for severe symptoms to manifest. Specific warnings exist for high-risk groups, including the elderly and pediatric patients with large ingestions, who require close observation for complications.

Therapeutic Uses of Ibubeta

What Ibubeta Treats: Main Uses and Benefits

Ibubeta is considered relevant for providing symptomatic relief across several key areas of discomfort and inflammation. It is applied in contexts where temporary, supportive assistance in symptom management is needed to help patients cope more steadily with difficult episodes. The active ingredient is relevant for easing symptoms that interfere with daily functioning across pain, fever, and inflammation.

The medicine is applied in addressing symptoms related to physical discomfort, such as headache, muscle aches, toothache, and menstrual cramps (dysmenorrhea). It is also commonly used in settings marked by temporary physiological imbalance, applied in addressing symptoms related to systemic imbalance, and is relevant for easing symptoms related to inflammatory or irritative states like osteoarthritis. This supportive therapeutic approach provides support that helps ease the overall symptom burden, which helps improve day-to-day comfort during symptomatic periods.

Quick Fact: Relief for Joint Stiffness Ibubeta is commonly used across conditions presenting with acute or recurrent episodes, where it assists in easing symptoms that create noticeable physiological strain.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Ibubeta, which contains the active substance ibuprofen, is a non-steroidal anti-inflammatory drug (NSAID) primarily used for pain and fever relief. Its use is generally considered safe for most adults and children over the age of three months (or older depending on formulation and weight), provided it's taken according to the recommended dose and duration.

However, certain individuals should not take Ibubeta due to the risk of serious side effects. Use is contraindicated in the following situations:

Condition
Known allergy or hypersensitivity to ibuprofen, aspirin, or other NSAIDs (which may cause asthma, runny nose, or hives).
Active or recurrent stomach/duodenal ulcers, gastrointestinal bleeding, or perforation.
Severe heart failure (NYHA Class IV), liver failure, or kidney failure.
The third trimester of pregnancy (after 20 weeks).
Recent or upcoming coronary artery bypass graft (CABG) surgery.

It is essential to consult a healthcare professional before using Ibubeta if you have a history of heart disease, high blood pressure, asthma, bleeding disorders, Crohn's disease, or systemic lupus erythematosus (SLE). Caution is also advised for the elderly due to an increased risk of adverse effects, particularly gastrointestinal bleeding and kidney problems.

What should I know about interactions with other medicines?

Ibubeta's interaction profile is officially defined by its effects on specific pharmacokinetic pathways and additive pharmacodynamic risks. Co-administration is formally contraindicated with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors and high-dose Aspirin (doses over 325 mg daily), due to an increased potential for gastrointestinal toxicity.

The medicine can alter the clearance of several agents, which may result in increased plasma concentrations and systemic exposure. This is officially documented with substances such as Lithium, Digoxin, and Methotrexate, where Ibuprofen may reduce their renal clearance. Similarly, the simultaneous use of potent CYP2C9 inhibitors may increase Ibubeta’s own systemic exposure.

A key regulatory constraint involves mandatory timing rules for patients using low-dose Aspirin (for cardiac protection). To prevent interference with Aspirin’s antiplatelet function, Ibubeta must be administered at least eight hours before or thirty minutes after the immediate-release Aspirin dose.

Additive pharmacodynamic effects pose interaction risks when co-administered with anticoagulants, antiplatelet agents, corticosteroids, and SSRIs or SNRIs, leading to an officially documented increased potential for bleeding. Furthermore, the regulatory label notes that the risk of bleeding may also be increased with the concomitant intake of alcohol or the herbal product Ginkgo biloba. The potential for serious gastrointestinal events is specifically noted as being higher in the elderly population when co-administered with other interacting agents.

Mechanism of Action

The drug's action involves modulating key physiological pathways by inhibiting specific enzyme activity. The mechanism targets processes influencing nociception and heat regulation, affecting both central and peripheral systems.

Targeting the Cyclooxygenase Enzyme System

The core mechanism involves the reversible, non-selective inhibition of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. By blocking these primary molecular targets, the molecule interrupts the early steps of the lipid mediator synthesis pathway, preventing the conversion of arachidonic acid into prostanoids. This enzymatic blockade reduces the production of key signaling molecules involved in physiological responses.

Modulation of Central and Peripheral Mediators

The reduction of prostaglandin synthesis affects the body via two primary physiological effects. Peripherally, the decreased concentration of Prostaglandin E2 (PGE2) prevents the chemical sensitization of nociceptors and reduces localized vascular permeability. Centrally, the drug acts in the hypothalamus to reduce PGE2 production, influencing the body's temperature set-point and initiating heat loss.

Dosage and Administration Information

Ibubeta is an oral, intravenous, or topical preparation of ibuprofen, and its use is guided by specific parameters. The most common administration method is the oral route, with dosing for acute symptoms typically ranging from 200 mg to 400 mg per dose.

These doses must be separated by a minimum interval of four to six hours, and chronic therapeutic use, such as for inflammatory conditions, requires the total daily dose to be divided and taken three to four times a day. The maximum prescribed daily dose is 3,200 mg. To mitigate gastrointestinal discomfort, the oral dosage forms are generally instructed to be taken with or after food or milk. Film-coated tablets must be swallowed whole, and liquid suspension forms require shaking before dose measurement.

In hospital settings where oral intake is not feasible, the medicine may be administered as an intravenous infusion. This route requires specific preparation and procedural conditions: the concentrated IV solution must first be diluted to a final concentration of 4 mg/mL or less. The resulting mixture must then be infused into the patient over a period of at least 30 minutes. For all routes, the medication is intended for short-term use, and the treatment of older adults should utilize the lowest effective dose for the shortest duration.

Recent Clinical Evidence

Research evidence / Overview of Studies for Ibubeta

Evidence for Use in Acute Mild to Moderate Pain

The research base for Ibubeta's active ingredient, Ibuprofen, includes numerous studies that examined outcomes related to physical discomfort. The research base is primarily composed of Randomized Controlled Trials (RCTs) and subsequent large-scale systematic reviews applied in research contexts involving fluctuating or unstable symptoms, such as pain following dental work, injuries, or headache.

In these short-term studies, researchers monitored patient-reported outcomes describing perceived discomfort. Studies conducted during periods of increased symptom activity reported the measurements of pain intensity scores in groups that received the active ingredient compared to groups that received an inactive substance. Findings from systematic reviews indicated that observed patterns were generally similar across different types of acute pain studied.

However, the evidence is limited regarding the effect of repeated, short-term use over days or weeks for recurrent pain. Follow-up durations were limited, often tracking outcomes only for the first few hours post-administration. Subgroup findings are uncertain for certain adult populations with underlying chronic conditions, as they are not the primary focus of most acute pain trials.


Evidence for Use in Fever Reduction

Ibubeta's component was studied for use in research exploring how symptoms change over time related to systemic or functional imbalance, specifically fever. The core evidence consists of many RCTs and numerous systematic reviews that compared Ibuprofen to placebo and other widely used fever-reducing medicines.

Research examined outcomes capturing phases of heightened symptom activity by monitoring core body temperature. Findings describe patterns observed in the studies, reporting that the core temperature measurements varied in the observed populations during the defined time intervals. The research is well-documented and extensive for the acute setting, but data for certain groups remain insufficient.


Research in Special Populations

Research has specifically evaluated the active ingredient in certain populations where symptoms may vary in intensity. The pediatric population has been well-studied, particularly concerning fever and acute pain. Studies conducted on children examined outcomes related to fever and acute pain, which are types of episodic changes in symptoms.

Evidence for use in older adults primarily comes from the inclusion of these individuals within the broader adult trials for acute and chronic conditions, as well as from observational studies. Research provides context but not individual predictions about whether an individual with certain pre-existing comorbidities will respond in the same way. Study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Ibubeta (FAQ)


Q: Is Ibubeta the same kind of medicine as Advil or Motrin?

The active ingredient in Ibubeta is Ibuprofen. Official product information confirms that Ibuprofen is the same core component found in other popular over-the-counter brands like Advil and Motrin. This classification indicates they belong to the same pharmacological group of medicines.


Q: Is Ibubeta safe for people who have sensitive stomachs?

Official warnings note that the medication is associated with gastrointestinal side effects, such as indigestion and nausea, and carries a risk of more serious events like bleeding. To help reduce stomach upset, the official directions often note that the medicine may be taken with food or milk. The regulatory label emphasizes risks for patients with existing GI issues.


Q: Can a person use Ibubeta if they are taking medicine for high blood pressure?

Regulatory warnings caution that NSAIDs may increase or worsen high blood pressure and may reduce the effectiveness of some blood pressure medications. Because of this potential interference, official sources specify that a consultation with a healthcare provider is required before use.


Q: What is the meaning of the warning about gastrointestinal bleeding with Ibubeta?

This warning means that the medication can cause ulceration, bleeding, or holes in the stomach or intestinal tract. According to regulatory documents, this serious complication can occur without any warning symptoms and may be fatal. This is why the product information emphasizes the risk factors for gastrointestinal events.


Q: Is there a maximum number of days Ibubeta should be used, according to official information?

For self-treatment of symptoms using over-the-counter products, official directions typically state specific duration limits. The labels generally specify use for no more than 10 days for pain or 3 days for fever, unless a healthcare provider specifies otherwise.


Q: What kind of research has been done on the long-term effects of Ibubeta?

Official summaries of clinical research focus primarily on the use of Ibubeta for short-term, acute symptoms like sudden pain or fever. Regulatory warnings indicate that using the medicine long-term is associated with an increased risk of serious side effects, particularly affecting the heart and stomach.


Q: Is the coating on Ibubeta tablets important?

Yes, regulatory directions state that film-coated tablets are required to be swallowed whole and not crushed. The coating is functionally important for the proper drug release and/or to protect the active ingredient or the stomach lining from irritation.


Q: Why is Ibubeta sometimes described as a 'non-steroidal' drug?

The medicine is officially classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). The 'non-steroidal' part of the name is a chemical designation, meaning the drug reduces inflammation similarly to corticosteroids but is chemically distinct and does not contain corticosteroids.


Q: Is it safe to drive or operate machinery after taking Ibubeta?

Official product information lists potential side effects such as dizziness, drowsiness, or visual disturbances. Caution is advised regarding driving or operating heavy machinery if an individual experiences any of these effects.


Q: What is the difference between prescription and over-the-counter Ibubeta?

The main difference, according to regulatory labels, is the dosage strength and the maximum daily dose. Prescription forms are available in higher strengths intended for specific chronic conditions, while over-the-counter forms are lower in dose and intended for general short-term use.


Q: How long does it usually take for Ibubeta to start working?

According to official information on its pharmacological properties, the effects of Ibubeta for pain relief generally begin within 20 to 30 minutes. Maximum pain relief is typically achieved within one to two hours after administration.


Q: What is the typical duration of relief from one dose of Ibubeta?

The duration of effective relief from a standard single dose of Ibubeta typically lasts for approximately four to six hours. This duration is consistent with the recommended dosing interval described in the official directions for use.


Q: Is it common to feel tired after taking Ibubeta?

While fatigue is not always listed as a common side effect, official adverse reaction reports include drowsiness and dizziness. In some cases, unusual tiredness may be a reported symptom noted in post-marketing data.


Q: Does Ibubeta interact with common cold or flu medications?

Official drug interaction warnings note that some cold and flu medications also contain an NSAID, often Ibuprofen. Because of the risk of increased side effects, the regulatory information recommends checking the active ingredients of all medicines to avoid taking two different NSAIDs simultaneously.


Q: Is Ibubeta available over the counter, or is a prescription always needed?

According to official regulatory documents on how the product is supplied, Ibubeta is available in both over-the-counter (OTC) forms and prescription forms. The required regulatory status depends on the specific dosage strength of the product.


Q: If I miss a dose of Ibubeta, what is generally described in official information?

Official directions for scheduled dosing typically describe a process where one takes the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the direction is to skip the missed dose and not take an extra amount.


Q: Are there any dietary restrictions mentioned in the official documents for Ibubeta?

Regulatory warnings highlight potential risks with alcohol consumption and the herbal product Ginkgo biloba. Both are specifically listed as having the potential to increase the risk of bleeding when taken with this medicine.


Q: What happens if someone takes too much Ibubeta, according to official reports?

In a situation where too much Ibubeta is taken, the official Overdosage section includes a warning that requires immediate medical help or contact with a Poison Control Center. Reported effects can vary but may include signs of severe allergic reactions or stomach bleeding.


Q: Is there a rebound effect when stopping Ibubeta use?

Official drug information states that Ibuprofen is not associated with physical dependence or withdrawal symptoms. However, if the medication is being used for chronic symptoms, the original pain or inflammation may naturally return or worsen when the treatment is discontinued.


Q: Does Ibubeta show up on standard drug tests?

Ibuprofen is an over-the-counter medication that is not typically screened for on standard workplace drug tests. However, post-marketing data suggests that in rare instances, it may cause a false positive result on some initial screening tests for other drug classes.


Q: Can a person take Ibubeta after receiving a vaccination?

According to official public health guidelines, the medication can be used after vaccination to help manage common symptoms like fever, pain, and discomfort. It is generally not recommended for use as a preventative measure before receiving a vaccine.


Q: Are there known genetic factors that affect how Ibubeta works for a person?

Official documents, including pharmacological summaries, note that the body metabolizes Ibuprofen using specific enzymes, such as CYP2C9. Genetic differences in the function of these enzymes can affect how quickly the drug is cleared, potentially influencing systemic exposure.


Q: What is the typical appearance of the Ibubeta tablet?

Official regulatory information describes the physical appearance of the tablets by specific dosage strength. For example, a high-dose tablet may be described as a white, round, biconvex film-coated tablet embossed with identification codes.


Q: Are there different brand names for the medicine known as Ibubeta?

Yes, official branding information confirms that Ibuprofen, the active ingredient in Ibubeta, is available under many different names. These include major brand names like Advil, Motrin, and various generic or store brands.


Q: Does official documentation mention using Ibubeta for menstrual cramps?

Yes, official regulatory documentation, typically in the Indications and Usage section, explicitly lists dysmenorrhea (menstrual cramps) as an approved indication for the treatment of pain.


Q: Is Ibubeta a habit-forming drug?

Official drug information, specifically the Drug Abuse and Dependence section, states that Ibuprofen is not associated with physical dependence or the potential for drug abuse or addiction. It is not classified as a habit-forming medication.

How should Ibubeta be stored and disposed of?

How to Store and Dispose of Ibubeta

Ibubeta (Ibuprofen) must be stored under specific regulatory conditions to maintain stability.


Storage Requirements

The required storage condition is typically Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), and products must avoid excessive heat above 40 C. Liquid formulations (suspensions) must not be frozen and should be kept in the original container with the cap tightly closed to protect from moisture.


Child Safety and Disposal

All Ibuprofen-containing products must be stored out of the sight and reach of children as a mandatory safety measure. Expired or unused medicine must not be thrown into household waste or flushed down the toilet. Dispose of the product by returning it to a pharmacy or utilizing a designated local medicine take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibubeta found in:

A-Z Index: